Suven Pharmaceuticals Cash Flow Annual

Trade
BSE: 543064 | NSE: SUVENPHAR | ISIN: INE03QK01018 | Sector: Biotechnology & Drugs
1,275.05 -19.30 (-1.49%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 405.67559.73667.59467.67
Depreciation/ Depletion 51.8146.4638.2631.22
Non- Cash Items -36.46-15.122.385.26
Changesin Working Capital -62.54-140.16-378.22-121.61
Cashfrom Operating Activities 358.48450.91330.00382.55
Capital Expenditures -51.79-285.77-75.19-110.85
Other Investing Cash Flow Items Total -310.4790.93-61.02-200.55
Cashfrom Investing Activities -362.25-194.84-136.21-311.40
Financing Cash Flow Items -7.45-5.44-6.14-8.67
Issuance( Retirement)of Debt Net -6.35-26.74-48.45-41.53
Cashfrom Financing Activities -13.80-235.83-156.41-75.66
Foreign Exchange Effects 0.000.000.000.00
Net Changein Cash -17.5720.2437.38-4.51
Cash Interest Paid 7.455.446.238.92
Cash Taxes Paid 109.95145.79184.26109.44
Total Cash Dividends Paid --203.65-101.83-25.46
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts